Latest Breaking News On - Beijing beilu - Page 1 : comparemela.com

[Latest] Global MRI Contrast Agents Market Size Worth 4 54 Billion by 2030 at a 6 2% CAGR: Custom Market Insights (Share, Report, Trends, Forecast, Trends, Segmentation)

[Latest] Global MRI Contrast Agents Market Size Worth 4 54 Billion by 2030 at a 6 2% CAGR: Custom Market Insights (Share, Report, Trends, Forecast, Trends, Segmentation)
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth africaSaudi arabiaSouth koreaJoel johnJodas expoimPharmazeutika gmbAsia pacificTaejoon pharmUnijules life sciencesTheir company profileIntersystems corporationTypes of servicesGlobal macroeconomic environment development trendsResearch key insights findings

China Iodixanol Market Report 2021-2025: A Third-Generation Contrast Agent that has Good Solubility and is Isotonic to Plasma

Share this article Share this article ResearchAndMarkets.com s offering. Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography, and so on. Iodixanol was developed by Nycomed, a Norwegian company, naming VISIPAQUE (Nycomed was acquired by GE after the merge with Amersham, and become GE Healthcare). In 2001, Iodixanol entered the Chinese market. Currently, besides GE Healthcare, the other main manufacturers in China are Jiangsu Hengrui Medicine, Yangtze River Pharmaceutical, Nanjing Chia Tai Tianqing Pharmaceutical, and Beijing Beilu Pharmaceutical. According to this market research, sales value of Iodixanol in the Chinese market has increased from 2016 to 2020. The sales value of Iodixanol in China reached approximately CNY1.49 billion in 2020, with an increase of 1.52% YoY.

Yangtze riverChina generalChia tai tianqingHuiyu jiangsu hengrui iodixanolBeilu iodixanolLaura woodJiangsu hengrui medicine co ltdOffice hours callInfluential factors of chinese iodixanol market developmentChia tai tianqing pharmaceutical co ltdYangtze river pharmaceutical groupYangtze river pharmaceutical group xiansuE st office hours callBeilu pharmaceutical co ltdDevelopment of iodixanolGe healthcare